Lead Sponsor

Novo Nordisk A/S

Age

All ages

Sex

MALE

Healthy Volunteers

No

•Male patients of all ages with the diagnosis of severe congenital haemophilia A (coagulation Factor VIII \[FVIII\] activity less than 1%) based on medical records
•On-going participation in NN7088-3859 (pathfinder2), or NN7088-3885 (pathfinder5) at the time of transfer

•Known or suspected hypersensitivity to trial product including allergy to hamster protein or related products
•Any disorder, except for conditions associated with haemophilia, which in the investigator's opinion might jeopardise patient's safety or compliance with the protocol - Current participation in any clinical trial (except NN7088-3859 (pathfinder2) or NN7088-3885 (pathfinder5)) of an approved or non-approved investigational medicinal product

Related studies

NCT03695978 · Haemophilia A

NCT06716814 · Haemophilia A (Moderate or Severe)

NCT07437404 · Haemophilia A

NCT06352216 · Haemophilia A, Synovitis, and more

NCT06831734 · Haemophilia A, Haemophilia B

A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A